ALNY vs ELV · P/E 76, rev $1.29B vs P/E 18, rev $199.13B
Alnylam Pharmaceuticals Inc (ALNY) versus Elevance Health Inc (ELV) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Elevance Health Inc (ELV) is a healthcare plans company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported ELV revenue for 2025-12-31 was $199.13B. Net income was $5.66B. Revenue was up 12.5% from 2024-12-31 to 2025-12-31. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. ELV currently screens at market cap $90.24B and trailing P/E 17.6.
Not investment advice. Open the ALNY and ELV stock pages for the full models.
Not investment advice.